Head and neck cancer is a term used to define cancer that develops in the mouth (oral cavity), throat, nose, salivary glands, oral cancers or other areas of the head and neck. Most of these are classified as squamous cases which cover the 90% of the disease area.
The head and neck district represents one of the most frequent sites of cancer, and the percentage of metastases is very high in both loco-regional and distant areas.
DelveInsight’s ” Head and neck cancer Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Head and neck cancer, historical and forecasted epidemiology as well as the Head and neck cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of the Head and neck cancer Market are:
According to World Health Organization, 2014, The annual incidence of head and neck cancers worldwide is more than 550,000 cases with around 300,000 deaths each year. Male to female ratio ranges from 2:1 to 4:1. About 90% of all head and neck cancers are squamous cell carcinomas (HNSCC).
As per the study conducted by Audrey Rousseau et al. 2011: SCC is the most frequent malignant tumor of the head and neck region. HNSCC represents the sixth leading cancer by incidence and there are 500,000 new cases a year worldwide (Kamangar et al., 2006).
Head and Neck is slightly more common in men than in women.
The major key players in the head and neck cancer are Merck, Immutep, Kura Oncology, Roche, AVEO Pharmaceuticals and others.
At ASCO 2021, AVEO Pharmaceuticals and Immutep presented the results from their respective clinical trials that demonstrated good clinical efficacy of their respective candidates (Ficlatuzumab and eftilagimod alpha, respectively)
The market size shall grow during the forecast period owing to the launch of upcoming therapies. The market size is expected to increase at a CAGR of XX during the study period.
As per the American Dental Association 2020: Squamous cell carcinoma (SCC) is the most common malignancy in the oral cavity (OC) and oropharynx (OP), accounting for 90% of cancers of the head and neck.
According to Siegel et al. (2017), head and neck cancer incidence rate is 20% higher in men than in women.
Head and neck cancer Companies in the market are:
Request for a sample report to know more in detail about the Head and neck cancer therapies and companies: https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market
Head and neck cancer therapies are:
Click here to know more in detail about the Head and neck cancer pipeline therapies: Head and neck cancer Therapies and Drugs
Scope of Head and Neck Cancer Report:
The report covers the descriptive overview of Head and Neck Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Head and Neck Cancer epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Head and Neck Cancer are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Head and Neck Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Head and Neck Cancer market
Know more about the scope of the Head and neck cancer market report, click here: https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market
Table of Contents:
1. Key Insights
2. Executive Summary of Head and Neck Cancer
3. Competitive Intelligence Analysis for Head and Neck Cancer
4. Head and Neck Cancer: Market Overview at a Glance
5. Head and Neck Cancer: Disease Background and Overview
6. Patient Journey
7. Head and Neck Cancer Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Head and Neck Cancer Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Head and Neck Cancer: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Head and Neck Cancer
17. KOL Views
18. Market Drivers
19. Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States